Clinical trials
Completed Phase 4 Heart Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2016 | 3 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 4 |
| The University of Texas Health Science Center, Houston | 3 |
| Weill Medical College of Cornell University | 3 |
| Biosense Webster, Inc. | 2 |
| Johns Hopkins University | 2 |
| St. Antonius Hospital | 2 |
| Texas Tech University Health Sciences Center | 2 |
| University of Minnesota | 2 |
| Asker & Baerum Hospital | 1 |
| Associations for Establishment of Evidence in Interventions | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 50 |
| Cardiovascular Diseases | 18 |
| Coronary Artery Disease | 11 |
| Myocardial Ischemia | 11 |
| Coronary Disease | 9 |
| Vascular Diseases | 9 |
| Myocardial Infarction | 6 |
| Arterial Occlusive Diseases | 5 |
| Heart Failure | 5 |
| Arteriosclerosis | 4 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.